Allarity Therapeutics, Inc. (ALLR) stock
ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.84−0.03 (-3.91%)
Close on Nov 17, 2026Market cap $13.38MP/E –Yield –
Allarity Therapeutics cash
Cash and short-term investments held at the end of each period.
Allarity Therapeutics's cash was $16.98M at Jun 30, 2026. For fiscal 2025 it was $14.69M, down 24.8% from the year before. The highest annual figure on record is $19.56M in fiscal 2021.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $14.69M | -24.8% |
| FY2024 | Dec 31, 2024 | $19.53M | +11666.9% |
| FY2023 | Dec 31, 2023 | $166.00K | -91.8% |
| FY2022 | Dec 31, 2022 | $2.03M | -89.6% |
| FY2021 | Dec 31, 2021 | $19.56M | +6462.1% |
| FY2020 | Dec 31, 2020 | $298.00K | -80.4% |
| FY2019 | Dec 31, 2019 | $1.52M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $16.98M | -4.6% |
| Q1 FY2026 | Mar 31, 2026 | $19.81M | -21.4% |
| Q4 FY2025 | Dec 31, 2025 | $14.69M | -24.8% |
| Q3 FY2025 | Sep 30, 2025 | $16.90M | -8.7% |
| Q2 FY2025 | Jun 30, 2025 | $17.80M | -7.4% |
| Q1 FY2025 | Mar 31, 2025 | $25.20M | +7977.2% |
| Q4 FY2024 | Dec 31, 2024 | $19.53M | +11666.9% |
| Q3 FY2024 | Sep 30, 2024 | $18.50M | +1222.4% |
| Q2 FY2024 | Jun 30, 2024 | $19.23M | +4479.3% |
| Q1 FY2024 | Mar 31, 2024 | $312.00K | -84.6% |
| Q4 FY2023 | Dec 31, 2023 | $166.00K | -95.8% |
| Q3 FY2023 | Sep 30, 2023 | $1.40M | -81.8% |
| Q2 FY2023 | Jun 30, 2023 | $420.00K | -97.1% |
| Q4 FY2022 | Dec 31, 2022 | $2.03M | -89.6% |
| Q3 FY2022 | Sep 30, 2022 | $3.95M | -29.3% |
| Q2 FY2022 | Jun 30, 2022 | $7.68M | +16.4% |
| Q1 FY2022 | Mar 31, 2022 | $14.54M | +13751.4% |
| Q4 FY2021 | Dec 31, 2021 | $19.56M | +6462.1% |
| Q3 FY2021 | Sep 30, 2021 | $5.58M | +18513.3% |
| Q2 FY2021 | Jun 30, 2021 | $6.60M | +332.9% |
| Q1 FY2021 | Mar 31, 2021 | $105.00K | – |
| Q4 FY2020 | Dec 31, 2020 | $298.00K | – |
| Q3 FY2020 | Sep 30, 2020 | $30.00K | – |
| Q4 FY2019 | Dec 31, 2019 | $1.52M | – |
See a number that looks wrong?